Regenxbio Inc RGNX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/10/24 EDT
15.44quote price arrow down-0.24 (-1.53%)
Volume
409,834
52 week range
11.83 - 28.80
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close15.44
  • 52 Week High28.80
  • 52 Week High Date03/05/24
  • 52 Week Low11.83
  • 52 Week Low Date02/02/24

Key Stats

  • Market Cap757.22M
  • Shares Out49.04M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • YTD % Change-13.98

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close15.44
  • 52 Week High28.80
  • 52 Week High Date03/05/24
  • 52 Week Low11.83
  • 52 Week Low Date02/02/24
  • Market Cap757.22M
  • Shares Out49.04M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • YTD % Change-13.98

RATIOS/PROFITABILITY

  • EPS (TTM)-5.88
  • P/E (TTM)-2.63
  • Fwd P/E (NTM)-3.14
  • EBITDA (TTM)-246.411M
  • ROE (TTM)-60.80%
  • Revenue (TTM)86.726M
  • Gross Margin (TTM)56.89%
  • Net Margin (TTM)-299.97%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Regenxbio Inc

 

Profile

MORE
REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three areas: retinal, neuromuscular and neurodegenerative diseases. Its investigational...
Allan Fox J.D.
Chairman of the Board
Kenneth Mills
President, Chief Executive Officer, Director
Curran Simpson
Chief Operating Officer, Executive Vice President
Vittal Vasista
Chief Financial Officer, Executive Vice President
Patrick Christmas II
Executive Vice President, Chief Legal Officer
Address
9804 Medical Center Drive
Rockville, MD
20850
United States

Top Peers

SYMBOLLASTCHG%CHG
SAGE
SAGE Therapeutics Inc
11.90-0.44-3.57%
YMAB
Y-mAbs Therapeutics Inc
12.28-0.59-4.58%
NRIX
Nurix Therapeutics Inc
13.51-0.44-3.15%
ZNTL
Zentalis Pharmaceuticals Inc
12.54+0.02+0.16%
IMTX
Immatics NV
10.83+0.19+1.79%